Conference coverage: Selected presentations from the 20th Annual Practical Approaches to the Treatment of Obesity; June 22-24, 2006

MedGenMed Medscape General Medicine

Volumn 8, Issue 4, 2006, Pages

  McDermott, Ann Yelmokas ^a   Kaplan, Lee ^b   Flier, Jeffrey S ^b   Drucker, Daniel J ^b   Malhotra, Atul ^b   Berkowitz, Robert I ^b   Jakicic, John ^b   Wadden, Thomas ^b   Herron, Daniel M ^b   Shikora, Scott ^b   Schwartz, Marlene ^b   Kushner, Robert F ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; OXYNTOMODULIN; PHENTERMINE; PLACEBO; PRAMLINTIDE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

BEHAVIOR THERAPY; BODY WEIGHT; CLINICAL TRIAL; CONFERENCE PAPER; CULTURAL FACTOR; DIET THERAPY; DISEASE MODEL; DISEASE SEVERITY; ELECTROSTIMULATION; ENERGY BALANCE; ENERGY EXPENDITURE; EXERCISE; GENE MUTATION; HEALTH CARE COST; HUMAN; LAPAROSCOPIC SURGERY; LIFESTYLE; MORBIDITY; MORTALITY; NAUSEA; NONHUMAN; OBESITY; PEDIATRICS; PHYSICAL ACTIVITY; PULMONARY HYPERTENSION; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 33846277615     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
2. Farooqi IS. Genetic and hereditary aspects of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005;19:359-374.
3. Farooqi IS, Mararese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093-1103.
4. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
5. Wynne K, Park AJ, Small CJ, t al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 2005;54:2390-2395.
6. Wynne K, Park AJ, Small CJ, et al. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes (Lond). 2006; [Epub ahead of print]. Available at: http://dx.doi.org/10.1038/ sj.ijo.0803344. Accessed November 29, 2006.
7. Troupin B, Lush C, Chen K, et al. A phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of rising doses of AC162352 (synthetic human PYY3-36) in lean and obese subjects. Presented at the 87th Annual Meeting of the Endocrine Society. June 4, 2005. Abstract OR58-1.
8. Chapman I, Parker B, Doran S, et al. Pramlintide reduced ad-libitem food intake and meal duration independently of ghrelin, PYY, CCK, and GLP-1: further evidence for a physiological role of amylin agonism in human appetite control. Presented at the 87th Annual Meeting of the Endocrine Society. June 7, 2005. Abstract OR58-5.
9. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515-520.
10. Drucker DJ. Title enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care. 2003;26:2929-2940.
11. Blonde L. Exenatide promotes weight loss in overweight diabetic patients. Presented at the NAASO Annual Scientific Meeting. October 18, 2005. Abstract 102-OR.
12. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163:205-209.
13. Patel S, Malhotra A, Gottlieb D, White D, Hu FB. Correlates of long sleep duration. Sleep. 2006;29:881-889.
14. Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep. 2004;27:661-666.
15. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005;28:1289-1296.
16. Spiegel K, Tasali E, Penev P, Cauter EV. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141:846-850.
17. Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237-245.
18. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-2594.
19. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352:1206-1214.
20. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337:869-873.
21. Must A, Jacques PF, Dallal GE, Bajema C, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1997;327:1350-1355.
22. Weiss R, Dziura J, Burgert T, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
23. Gahagan S, Silverstein J; American Academy of Pediatrics Committee on Native American Child Health, American Academy of Pediatrics Section on Endocrinology. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. Pediatrics 2003;112:e328-e329.
24. Epstein L, Valoski A, Wing RR, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol. 1994;13:373-383.
25. Wadden TA, Stunkard AJ, Rich L, Rubin C, Sweidel G, McKinney S. Obesity in black adolescent girls: a controlled clinical trial of treatment by diet, behavior modification, and parental support. Pediatrics. 1990;85:345-352.
26. Berkowicz RI, Wadden TA, Tershakovec A, Cronquist J. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA. 2003;289:1805-1812.
27. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obesity Res. 2002;10:642-650.
28. Chanoine J, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293:2873-2883.
29. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care. 2004;27:596-601.
30. Donnelly JE, Hill JO, Jacobsen DJ, et al. Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: The Midwest Exercise Trial. Arch Intern Med. 2003;163:1343-1350.
31. Jakicic JM. The role of physical activity in prevention and treatment of body weight gain in adults. J Nutr. 2002;132:3826-3829.
32. Wadden TA, Didie E. What's in a name? Patients' preferred terms for describing obesity. Obesity Res. 2003;11:1140-1146.
33. Klem ML, Wing RR, McGuire M, Seagle H, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66:246.
34. Brownell KD. The LEARN Program For Weight Management. Dallas, Texas: American Health Publishing Company; 2004. (Other editions: 1987, 1989, 1990, 1991, 1994, 1997, 2000, and 2002)
35. Wing RR, Hill JO. Successful weight loss maintenance. Ann Rev Nutr. 2001;21:323-341.
36. Wadden TA, Berkowicz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111-2120.
37. Jan JC, Hong D, Pereira N, Patterson EJ. Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results. J Gastrointest Surg. 2005;9:30-41.
38. Deitel M, Cowan GSM Jr. Update: Surgery for the Morbidly Obese Patient. Toronto, Ontario, Canada: FD-Communications, Inc; 2000: 529.
39. Provost D. Laparoscopic adjustable gastric banding: an attractive option. Surg Clin North Am. 2005;85:789-805.
40. Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg. 2005;201:529-535.
41. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
42. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg. 2000;4:598-605.
43. Schwartz MB, Chambliss HO, Brownell KD, Blair SN, Billington C. Weight bias among health professionals specializing in obesity. Obesity Res. 2003;11:1033-1039.
44. Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr. 2004;79:6-16.
45. Wansink B, Painter JE, Lee Y-K. The office candy dish: proximity's influence on estimated and actual consumption. Int J Obes. 2006;30:875.
46. Department of Health and Humans Services. Division of Nutrition and Physical Activity: Publications. 54 (47), 1208-1212. 12-2-2005. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ nccdphp/dnpa/publications/index.htm. Accessed November 29, 2006.
47. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
48. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
49. Miech RA, Kumanyika SK, Stettler N, Link BG, Phelan JC, Chang VW. Trends in the association of poverty with overweight among US adolescents, 1971-2004. JAMA. 2006;295:2385-2393.
50. Oldenburg B, Sallis JF, Harris D, Owen N. Checklist of Health Promotion Environments at Worksites (CHEW): development and measurement characteristics. Am J Health Promotion. 2002;16:288-299.